Good evening :)
Switch to
Place Order

How to use scorecard? Learn more

Glenmark Pharmaceuticals Ltd

GLENMARK
Health CarePharmaceuticals
SmallcapWith a market cap of ₹17,439 cr, stock is ranked 258
Moderate RiskStock is 2.44x as volatile as Nifty
631.502.18% (+13.45)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹17,439 cr, stock is ranked 258
Moderate RiskStock is 2.44x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
58.681.850.40%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
34.234.590.82%

Forecast & RatingsDetailed Forecast 

35%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Glenmark Pharmaceuticals Limited is a global pharmaceutical company engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs).

Investor PresentationView older 

May 19, 2023

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2020202120222023+10.83+11.04+12.47+13.31+0.78+0.97+0.94+0.30
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Updates 
Announced OnMay 31, 2023
Glenmark Pharmaceuticals Limited has inf | Download
Annual Secretarial Compliance Report 
Announced OnMay 25, 2023
Annual Secretarial Compliance Report for | Download
Cash Dividend 
Ex. DateSep 12, 2022

Final • Div/Share: ₹ 2.5

See all events